rrRCC Treatment Research May Provide Hope for Patients | AVEO Oncology
This site is intended for US healthcare professionals.
This site is intended for
US healthcare professionals.

Late-line Benefits

Achieving Later-Line Benefits

Research is pursuing effective and tolerable therapy, potentially offering hope for patients with rrRCC15,16

  • Because treatment decisions take into account safety and tolerability, including the impact of comorbidities and prior therapies,8 the development of well-tolerated treatment options is essential to continuing care
  • Delaying symptoms is an essential goal: progressing symptomatic disease imposes a significant burden of complications, pain, and physical limitations, negatively impacting quality of life17
  • As RCC advances, quality of life implications become increasingly important18

Finding effective and tolerable treatment is especially critical in later-line RCC since AEs continue to pose a clinical challenge and poor performance status can be a barrier to receiving therapy13,19